These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21332920)

  • 21. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a new aluminium salt thermophobic foam in the treatment of axillary and palmar primary hyperhidrosis: a pilot exploratory trial.
    Innocenzi D; Lupi F; Bruni F; Frasca M; Panetta C; Milani M
    Curr Med Res Opin; 2005 Dec; 21(12):1949-53. PubMed ID: 16368045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A.
    Skroza N; Bernardini N; La Torre G; La Viola G; Potenza C
    Acta Dermatovenerol Croat; 2011; 19(1):16-20. PubMed ID: 21489361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromhidrosis induced by sphingomonas paucimobilis: a case report.
    Mancini M; Panasiti V; Devirgiliis V; Pietropaolo V; Fioriti D; Nicosia R; Curzio M; Roberti V; Gobbi S; Bottoni U; Chiarini F; Calvieri S
    Int J Immunopathol Pharmacol; 2009; 22(3):845-8. PubMed ID: 19822101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation and quantitative analysis of axillary hyperhidrosis treated with a unique targeted laser energy delivery method with 1-year follow up.
    Caplin D; Austin J
    J Drugs Dermatol; 2014 Apr; 13(4):449-56. PubMed ID: 24719065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innervation and receptor profiles of the human apocrine (epitrichial) sweat gland: routes for intervention in bromhidrosis.
    Lindsay SL; Holmes S; Corbett AD; Harker M; Bovell DL
    Br J Dermatol; 2008 Sep; 159(3):653-60. PubMed ID: 18637900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
    Solish N; Benohanian A; Kowalski JW;
    Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperhidrosis, bromhidrosis, and chromhidrosis: Fold (intertriginous) dermatoses.
    Semkova K; Gergovska M; Kazandjieva J; Tsankov N
    Clin Dermatol; 2015; 33(4):483-91. PubMed ID: 26051066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical atropine sulfate for the treatment of axillary hyperhidrosis.
    Grimalt R; Domínguez Tordera P; Callejas MA
    J Cosmet Dermatol; 2006 Dec; 5(4):294-6. PubMed ID: 17716247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperhidrosis and bromhidrosis -- a guide to assessment and management.
    Perera E; Sinclair R
    Aust Fam Physician; 2013 May; 42(5):266-9. PubMed ID: 23781522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumescent suction curettage versus minimal skin resection with subcutaneous curettage of sweat glands in axillary hyperhidrosis.
    Wollina U; Köstler E; Schönlebe J; Haroske G
    Dermatol Surg; 2008 May; 34(5):709-16. PubMed ID: 18318727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Novel adverse effects of laser-assisted axillary hair removal].
    Hélou J; Soutou B; Jamous R; Tomb R
    Ann Dermatol Venereol; 2009; 136(6-7):495-500. PubMed ID: 19560609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study.
    Glogau RG
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S76-80. PubMed ID: 17241418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous ethanol injection for the treatment of axillary osmidrosis.
    Han X; Li F
    Clin Exp Dermatol; 2013 Jul; 38(5):484-8. PubMed ID: 23777489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical validation of efficacy and safety of herbal cough formula: study of herbal cough syrup.
    Nesari T; Bhagwat BK; Johnson J; Bhatt NS; Chitre D
    J Herb Pharmacother; 2004; 4(4):1-12. PubMed ID: 15927921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An open-label trial of the efficacy of 15% aluminum chloride in 2% salicylic acid gel base in the treatment of moderate-to-severe primary axillary hyperhidrosis.
    Flanagan KH; Glaser DA
    J Drugs Dermatol; 2009 May; 8(5):477-80. PubMed ID: 19537371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of hyperhidrosis by topical application of a local anesthetic composition.
    Juhlin L; Evers H; Broberg F
    Acta Derm Venereol; 1979; 59(6):556-9. PubMed ID: 94225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.